SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Biotech Bay
Gilead’s 3 Biggest Goofs of 2016
December 7, 2016
 · 
3 min read
BioCapital
Pfizer, Gilead and Incoming Eli Lilly CEO Discuss Why People Don’t Like or Trust Pharma Companies
December 2, 2016
 · 
1 min read
Gilead Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma
Biotech Bay
A Look at Gilead and Its Potential $10 Billion Blunder
December 2, 2016
 · 
3 min read
Biotech Bay
When Will Gilead’s Unlucky Streak End?
November 23, 2016
 · 
1 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Business
Reeling From GlobeImmune Hepatitis B Termination, Gilead Faces Merck & Co., GlaxoSmithKline Competition
November 22, 2016
 · 
2 min read
Biotech Bay
Does Gilead Pass Warren Buffett’s Test?
November 18, 2016
 · 
1 min read
Gilead Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma
Deals
Gilead’s R&D Woes Could Make it an Attractive Target for Allergan and Pfizer
November 18, 2016
 · 
3 min read
Ex-Akebia Director Re-arrested After Insider Trading Prosecutors Call Him Unhinged
Business
Embattled GlobeImmune Loses Gilead Deal, Cancels HQ Lease, and CEO Resigns
November 17, 2016
 · 
2 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Drug Development
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
November 17, 2016
 · 
3 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Gilead’s GS-4997 Meets Goals in Mid-Stage NASH Trial, But Flunks Studies In PAH And DKD
October 20, 2016
 · 
6 min read
Drug Development
Gilead Announces SVR12 Rates From Four Phase III Studies Of A Once-Daily, Fixed-Dose Combination Of Sofosbuvir, Velpatasvir And Voxilaprevir In Treatment-Naïve And Treatment-Experienced Genotype 1-6 Chronic HCV-Infected Patients
October 20, 2016
 · 
6 min read
Business
Gilead And WHO Announce Five-Year Visceral Leishmaniasis Collaboration
September 28, 2016
 · 
4 min read
Drug Development
Gilead Looks Over Shoulder as Johnson & Johnson Eyes Taking a Bite Out of Hep C Market
September 12, 2016
 · 
1 min read
Biotech Bay
Gilead To Present At Three Upcoming Investor Conferences In September
September 6, 2016
 · 
1 min read
Business
How Gilead Can Make Another $10 Billion Every Year
August 31, 2016
 · 
1 min read
Business
Kelly A. Kramer Joins Gilead’ Board of Directors
August 23, 2016
 · 
1 min read
Biotech Bay
European Commission (EC) Grants Marketing Authorization For Gilead’s Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1
August 22, 2016
 · 
4 min read
Business
Genmab A/S Scores $277 Million DuoBody Technology Tie-Up With Gilead
August 11, 2016
 · 
4 min read
Business
How Japan Played a Big Role in Gilead’s Dismal Quarter
August 5, 2016
 · 
1 min read
Load More